OCUL 8-K 2026-11-09

OCULAR THERAPEUTIX, INC (OCUL) 8-K dated 2026-11-09 — accession 0001104659-26-124159.

OCULAR THERAPEUTIX, INC (OCUL) is a biotechnology company listed on US.

OCULAR THERAPEUTIX, INC filed a 8-K on 2026-11-09. Accession 0001104659-26-124159.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Latest reported OCUL revenue for 2025-12-31 was $52.0M. Net income was -$265.9M. Revenue was down 18.5% from 2024-12-31 to 2025-12-31. OCUL currently screens at market cap $1.76B.

Not investment advice. The OCUL SEC hub lists recent forms. The stock page is the research view.